Skip to content
Friday 14 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,750.11
-0.21%
DAX
26,440.31
+0.53%
CAC 40
8,636.80
-0.16%
STOXX 50
6,539.59
-0.09%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE
Tuesday 05 April 2022 1:26 pm

Drug-drivers could be forced to take rehabilitation courses before using cars under new government plan

By: Ilaria Grasso Macola

Add as a preferred source on Google
New data this morning showed that the number of people killed or seriously injured (KSI) in drink-driving crashes rose to an eight-year high in 2019.
Drivers have suffered at the pump

Drug-drivers could be forced to take rehabilitation courses before being allowed to get behind the wheel, according to proposed government plans.

Transport secretary Grant Shapps today launched a call for evidence to decide whether those who had been caught drug-driving need to follow in drink-drivers’ footsteps and complete rehabilitation.

“If we are to make our roads safer still, there is no room to be lax on drug-driving, which is why I have launched this call for evidence today,” he said.

“It’s only right that drug-drivers must undergo rehabilitation before getting back behind the wheel, helping protect the public from this hidden problem and stamping out drug-driving for good.”

While the number of drink-drive related deaths has gone down 88 per cent between 1979 and 2015, drug-driving collisions have gone up significantly over the last few years.

In 2016 the number of injuries in drug-driving car accidents was 499 but went up to 713 in 2020, with police arresting more drug-drivers than drunk ones.

RAC’s head of roads policy Nicholas Lyes welcomed the government decision, saying rehabilitation courses help to “reduce reoffending and improve road safety.”

Read more

Cycle Pharmaceuticals Selects Forma Life Sciences to Establish U.S. Commercial Supply for FDA-Approved CAVHANZA™ (nilotinib) Orally Disintegrating Tablets

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Transport & Infrastructure

Related Topics

  • UK Government

Trending Articles

  • Revolut takes flight with launch of new airport lounges

  • Grandparents fund university degrees to avoid inheritance tax net

  • Brompton Bicycle sues former adviser for ‘professional negligence’

  • Revolut chatbot goes rogue by charging users to cancel subscription

  • It’s not just Jason Arday, most of sociology is a scam

More from Morning Wire

  • Cycle Pharmaceuticals Selects Forma Life Sciences to Establish U.S. Commercial Supply for FDA-Approved CAVHANZA™ (nilotinib) Orally Disintegrating Tablets

    Business Wire
  • Iksuda receives US FDA IND clearance for IKS04

    Business Wire
  • Compass Pathways Announces Second Quarter and First Half 2026 Financial Results and Business Highlights

    Business Wire
  • Patent cliff fuels Novartis’ $1.5bn swoop for London biotech

    Healthcare
    Hikma produces generic drugs
  • e.l.f. Cosmetics is Giving Away Thousands of Driving Lessons to UK Learners

    Business Wire
  • Get ready for new energy minister Miatta Fahnbulleh’s war on London’s drivers

    Opinion
    Miatta Fahnbulleh, director of New Economics Foundation, smiling and holding red documents, wearing a black blazer.
  • ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults; alongside INSTI-powered long-acting injectable innovation at AIDS 2026

    Business Wire
  • Give London power to level up the rest of the country

    Opinion
    Business professionals in formal attire engaged in a lively discussion at a corporate meeting in a modern office setting.
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook